Skip to Main Content

Paper Details

Rituximab-Associated Progressive Multifocal Leukoencephalopathy: A Twenty-Year Update.
Cancer Treat Res
0
2022
John-Cunningham virus, PML, Progressive Multifocal Leukoencephalopathy, Progressive multifocal leukoencephalopathy, Rituximab, anti-CD20 monoclonal, persons, rituximab
Author NameAffiliation
Charles L BennettUniversity of South Carolina College of Pharmacy
Charles L BennettUniversity of South Carolina College of Pharmacy
  • 1 - 2

Datasets

Release 1.2